Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer

BACKGROUND: Adjuvant endocrine therapy (AET) is prescribed to women for 5–10 years after treatment for estrogen receptor positive (ER+ve), early-stage breast cancer. AET has proven effectiveness in reducing the risk of recurrence of breast cancer and mortality. However, adherence is known to be subo...

Descripción completa

Detalles Bibliográficos
Autores principales: Brett, Jo, Boulton, Mary, Watson, Eila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294163/
https://www.ncbi.nlm.nih.gov/pubmed/30587936
http://dx.doi.org/10.2147/PPA.S187692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294163/
https://www.ncbi.nlm.nih.gov/pubmed/30587936
http://dx.doi.org/10.2147/PPA.S187692

Ejemplares similares